Antistaphylococcal penicillins are recommanded as first-line agent in methicillin-suceptible Staphylococcus aureus bacteraemia. Several studies in progress are investigating the efficacy and safety of cefazolin compared with antistaphylococcal penicillins. Cefazolin has broader spectrum than antistaphylococcal penicillins. The hypothesis of this project is that cefazoline could be responsible for a higher rate of bacterial resistance. The aim is to study the association between the emergence of bacterial resistance and the consumption of cefazolin and antistaphylococcal penicillins.
Study Type
OBSERVATIONAL
Enrollment
644
Lefevre
Nancy, Lorraine, France
Association between the cefazolin/antistaphylococcal penicillins consumptions and the resistant bacteria emergence
The total consumption of antibiotics (expressed as number of Defined Daily Doses (DDD) per 1000 inhabitants per day) will be correlate with the resistant bacteria emergence (only incidence for each bacterial strain)
Time frame: Between the first january 2018 and the 31st december 2022
Factors associated with the emergence of resistant bacteria
Factors associated with the emergence of resistant bacteria will be described by a Cox model: hospital size (number of beds), location in France, activities (intensive care, surgery, etc.), type of antibiotics and intensity of consumption expressed in number of defined daily doses (DDD).
Time frame: Between the first january 2018 and the 31st december 2022
Factors associated with the consumption of antibiotics
Factors associated with the emergence of resistant bacteria will be described by a Cox model: hospital size (number of beds), location in France, activities (intensive care, surgery, etc.) and type of bacterial strain indentified (resistant or not).
Time frame: Between the first january 2018 and the 31st december 2022
Evolution of resistance in French hospitals
For each year, bacterial resistance will be described, in France and in each hospital, in the form of a quantitative variable: number of resistant bacterial strains isolated for each year (number of resistant strains / total number of strains).
Time frame: Between the first january 2018 and the 31st december 2022
Evolution of antibiotics consumption in French hospitals
For each year, antibiotic consumption will be described, in France and in each hospital, in the form of a quantitative variable (expressed as number of Defined Daily Doses (DDD) per 1000 inhabitants per day)
Time frame: Between the first january 2018 and the 31st december 2022
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.